International consensus statement on allergy and rhinology: rhinosinusitis 2021
RR Orlandi, TT Kingdom, TL Smith… - International forum of …, 2021 - Wiley Online Library
I. Executive Summary Background The 5 years since the publication of the first International
Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR‐RS) has witnessed …
Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR‐RS) has witnessed …
International consensus statement on allergy and rhinology: rhinosinusitis
RR Orlandi, TT Kingdom, PH Hwang… - International forum of …, 2016 - Wiley Online Library
Contributing Authors Isam Alobid, MD, PhD1, Nithin D. Adappa, MD2, Henry P. Barham,
MD3, Thiago Bezerra, MD4, Nadieska Caballero, MD5, Eugene G. Chang, MD6, Gaurav …
MD3, Thiago Bezerra, MD4, Nadieska Caballero, MD5, Eugene G. Chang, MD6, Gaurav …
Understanding the immunology of asthma: Pathophysiology, biomarkers, and treatments for asthma endotypes
MD Gans, T Gavrilova - Paediatric respiratory reviews, 2020 - Elsevier
Asthma is a common disease in paediatrics and adults with a significant morbidity, mortality,
and financial burden worldwide. Asthma is now recognized as a heterogeneous disease …
and financial burden worldwide. Asthma is now recognized as a heterogeneous disease …
[HTML][HTML] Asthma biomarkers in the age of biologics
H Kim, AK Ellis, D Fischer, M Noseworthy… - Allergy, Asthma & …, 2017 - Springer
The heterogeneous nature of asthma has been understood for decades, but the precise
categorization of asthma has taken on new clinical importance in the era of specific biologic …
categorization of asthma has taken on new clinical importance in the era of specific biologic …
Immunological biomarkers in severe asthma
D Narendra, J Blixt, NA Hanania - Seminars in immunology, 2019 - Elsevier
Severe asthma is heterogeneous in its clinical presentation, underlying pathophysiology,
course and response to therapy. Clinical and physiological assessment of severe asthma is …
course and response to therapy. Clinical and physiological assessment of severe asthma is …
[HTML][HTML] NSAID-exacerbated respiratory disease (NERD): from pathogenesis to improved care
Nonsteroidal antiinflammatory drug (NSAID)-exacerbated respiratory disease (NERD) is
characterized by moderate-to-severe asthma and a higher prevalence of chronic …
characterized by moderate-to-severe asthma and a higher prevalence of chronic …
Aspirin-exacerbated respiratory disease as an endotype of chronic rhinosinusitis
WW Stevens, RP Schleimer - … and Allergy Clinics, 2016 - immunology.theclinics.com
Chronic rhinosinusitis with nasal polyps (CRSwNP) and aspirin-exacerbated respiratory
disease (AERD) are both conditions characterized by the presence of chronic sinonasal …
disease (AERD) are both conditions characterized by the presence of chronic sinonasal …
Comparison of the clinical outcomes of patients with NSAID-exacerbated respiratory disease receiving aspirin or biologicals
G Tuncay, E Damadoglu, M Cihanbeylerden… - Journal of …, 2023 - Taylor & Francis
Objective NSAID-exacerbated respiratory disease (NERD) is characterized by exacerbation
of respiratory symptoms after NSAID intake. While research for specific treatment options …
of respiratory symptoms after NSAID intake. While research for specific treatment options …
Variation in doses and duration of particulate matter exposure in bronchial epithelial cells results in upregulation of different genes associated with airway disorders
P Tripathi, F Deng, AM Scruggs, Y Chen, SK Huang - Toxicology in Vitro, 2018 - Elsevier
Abstract Exposure to particulate matter< 2.5 μm (PM 2.5) is associated with a variety of
airway diseases. Although studies have demonstrated that high doses of PM 2.5 cause …
airway diseases. Although studies have demonstrated that high doses of PM 2.5 cause …
Genetic and epigenetic components of aspirin-exacerbated respiratory disease
A Dahlin, ST Weiss - Immunology and Allergy Clinics, 2016 - immunology.theclinics.com
Aspirin intolerance is a severe and rare asthmatic endotype, with prevalence rates of 10% in
the adult asthmatic population and up to 25% in patients with severe, persistent asthma. 1–4 …
the adult asthmatic population and up to 25% in patients with severe, persistent asthma. 1–4 …